Company / Book Value per Share
Kymera Therapeutics, Inc. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$24.344
FY2025
5-year range
-$1.673 / $24.344
FY2021-FY2025
Trend
+61.9%
vs FY2024
Sector context
#20 of 209
Health Care
What the data says
Among 209 Health Care companies, Kymera Therapeutics, Inc. is in the top 10% for book value per share. Improved from $8.23 to $24.344 over the past 2 years.
Based on SEC 10-K filings.
$24.344 in FY2025 with a 3-year CAGR of +36.8%. Top quartile in the Health Care sector.
Improved from $8.23 to $24.344 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +36.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 209This company $24.344 Sector average $215.686
▼
-88.7% below sector average
Key checks
Key Insights
- 3-year CAGR of +36.8%, indicating consistent growth.
- In FY2025, book value per share increased 61.9% year-over-year.
- Ranks #20 out of 209 companies in the Health Care sector.
- Lowest book value per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.344 | +61.9% |
| FY2024 | $15.033 | +82.7% |
| FY2023 | $8.23 | -13.5% |
| FY2022 | $9.511 | +668.6% |
| FY2021 | -$1.673 | +90.6% |
| FY2020 | -$17.847 | +59.3% |
| FY2019 | -$43.806 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026